Expression and clinical significance of interleukin-6 and interleukin-17 in patients with chronic rhinosinusitis

Abstract

Objective To evaluate the expression of interleukin-6 (IL-6) and interleukin-17 (IL-17) in patients with chronic rhinosinusitis (CRS),and analyze the effects of IL-6 and IL-17 on the occurrence and development of CRS.Methods Selected 200 CRS patients who planned to receive operation treatment,including 36 cases with type Ⅰ,139 cases with type Ⅱ and 25 cases with type Ⅲ,and they were chosen as CRS group and divided into nasal polyps group ( 109 cases) who had nasal polyps and no nasal polyps group (91 cases) who didn't have nasal polyps.And 50 healthy subjects were chosen as control group.The plasma IL-6 and IL-17 concentration were detected by double-antibody sandwich ELISA method.Results The plasma IL-6 and IL-17 levels of CRS group were (13.23 ±5.94),(9.24 ±4.15) ng/L respectively,significantly higher than those of control group[ (2.26 ± 1.01 ),( 1.58 ± 0.71 ) ng/L] (P ＜ 0.05 ),there was no significant difference between nasal polyps group and no nasal polyps group (P ＞ 0.05 ).The plasma IL-6 levels in type Ⅰ, Ⅱ and Ⅲ were (4.54 ±2.04),(12.90 ±5.80),(27.42 ± 12.32) ng/L respectively,and IL-17 levels were (3.17 ± 1.42),(9.01 ± 4.05),( 19.15 ± 8.61 ) ng/L,there were statistical differences among different clinical types (P ＜ 0.05).The plasma IL-6 and IL-17 level of CRS patients had significantly positive correlation (r =0.519,P ＜ 0.05).Conclusions The IL-6 and IL-17 expression are closely relatcd to the occurrence and development of CRS. Key words: Sinusitis; Interleukin-6; Interleukin-17